- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0009899

About Gelnova Laboratories (India) Private Limited
Data last updated:
Gelnova Laboratories (India) Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 January 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U17000MH1997PTC105076. Its GSTIN is 27AABCG6002C1Z9 (Maharashtra).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.3 Cr. It was formerly known as Franco Fabrics Private Limited. It is led by directors including Jatin Vasant Thakkar (Managing Director) and Bharati Vasant Thakkar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C – 125 Ttc Industrial Area Mahape, Navi Mumbai, Maharashtra, India – 400705.
As per the financials filed for FY 2025, the company reported a revenue of ₹61.38 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹77.7 Lakh (net margin 1.3%) and EBITDA of ₹4.29 Cr (EBITDA margin 7%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 6% over five years.
The company has about 82 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Gelnova. As per MCA filings, the company has open charges of ₹28.66 Cr and satisfied charges of ₹101.69 Cr on record. Court records list 21 cases involving the company, including 18 filed by the company and 3 filed against it. The company has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹50 Lakh; the latest was in March 2023. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 2 smaller; the largest is MDC Pharmaceuticals Limited with revenue of ₹61.89 Cr. The company has 19 MSME Form 1 returns on record between 2013 and 2023, listing 1,674 overdue payments to 124 micro and small suppliers.
Gelnova Laboratories (India) Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0009899). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gelnova.com.
Company details
Recognitions & Rankings of Gelnova Laboratories (India)
Contact details
Gelnova Laboratories (India) Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is gelnova.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC – 125 Ttc Industrial Area Mahape, Navi Mumbai, Maharashtra, India – 400705
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Gelnova Laboratories (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Gelnova Laboratories (India) operates one associated brand: Gelnova. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of Soft Gelatin Capsules and Lozenges for pharmaceutical applications in India. | gelnova.com |
Business activity
The main business activity of Gelnova Laboratories (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities |
To see the full business activity and turnover split of Gelnova Laboratories (India) Private Limited, buy the company report.
Financials of Gelnova Laboratories (India) Private Limited
FY 2024 filings availableGelnova Laboratories (India) Private Limited reported revenue of ₹61.38 Cr (down 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.29 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹77.7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gelnova Laboratories (India) Private Limited, buy the company report.
Board of directors of Gelnova Laboratories (India) Private Limited
Gelnova Laboratories (India) has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bharati Vasant Thakkar | Director | 18 Aug 2000 | 26 Years 2 Months | Current |
| Jatin Vasant Thakkar | Managing Director | 30 Sep 2015 | 11 Years 1 Months | Current |
| Dhananjay Thakorbhai Desai Also directs: Pharma Base India Private Limited, Sidmak Laboratories (India) Private Limited, Ostern Pvt Ltd and 4 more | Director | 15 Oct 2009 | 17 Years 0 Months | Current |
Peer comparison
Gelnova Laboratories (India) Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| MDC Pharmaceuticals Limited | ₹61.89 Cr (FY 2024) | 14.0% | Chandigarh, India | |||
| DNV Overseas Impex Private Limited | ₹61.67 Cr (FY 2018) | 74.0% | New Delhi, Delhi, India | |||
| Unijules Life Sciences Limited | ₹61.64 Cr (FY 2018) | -4.0% | Nagpur, Maharashtra, India | |||
| Revat Laboratories Private Limited | ₹61.45 Cr (FY 2025) | 10.0% | Hyderabad, Telangana, India | |||
| Gelnova Laboratories (India) Private Limitedthis company | ₹61.38 Cr (FY 2025) | ₹77.7 Lakh | 1.3% | -4.0% | 82 | Navi Mumbai, Maharashtra, India |
| Mistair Health and Hygiene Private Limited | ₹61.27 Cr (FY 2025) | -21.0% | Mumbai, Maharashtra, India | |||
| Gentech Healthcare Private Limited | ₹61.04 Cr (FY 2025) | 15.0% | New Delhi, Delhi, India |
To see the full peer comparison of Gelnova Laboratories (India) Private Limited, buy the company report.
Auditor
Gelnova Laboratories (India) Private Limited is audited by E. A. Patil & Associates LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| E. A. Patil & Associates LLP | FY 2023 | 117371W/W100092 |
Shareholding
The shareholding of Gelnova Laboratories (India) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Gelnova Laboratories (India) Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Oct 2023 | 100794007 | Others | ₹28 Cr | Open | |
| 19 May 2023 | 100721348 | Axis Bank Limited | ₹65.95 Lakh | Open | |
| 09 Mar 2021 | 100429857 | Others | ₹3.01 Cr | Satisfied | |
| 29 Jun 2020 | 100350651 | Others | ₹19 Cr | Satisfied | |
| 31 Jan 2018 | 100171061 | Others | ₹17 Cr | Satisfied |
To see the full charge records of Gelnova Laboratories (India) Private Limited, buy the company report.
Total charge records: 11 View all charges
Deals & funding
Gelnova Laboratories (India) Private Limited has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹50 Lakh; the latest was in March 2023.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Seller: 4 individuals |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: Jatin Vasant Thakkar HUF, 3 individuals Seller: 2 individuals |
| Sep 2010 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 3 individuals |
| Mar 2009 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
To see the full deal history of Gelnova Laboratories (India) Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Gelnova Laboratories (India) Private Limited has 21 court cases on record: 18 filed by Gelnova Laboratories (India), 3 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 13 | 3 | 0 |
| District courts | 8 | 0 | 0 |
Cases on record (5 of 21)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Court case (Sum.Civ.Suit) | Filed by the company against Elder Pharmaceuticals Ltd | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed by the company against M/S Colinz Laboratories Ltd. | Disposed |
| District court, Thane, Maharashtra | Court case (Sum.Civ.Suit) | Filed by the company against Indusken Pharmaceuticals Pvt Ltd | Disposed |
| Bombay High Court | Court case (SJ) | Filed by the company against M/S. Wizard Biotech Pvt.Ltd. | Disposed |
| Bombay High Court | Court case (CHS) | Filed by the company against M/S Colinz Laboratories Ltd. | Disposed |
To see the full case history of Gelnova Laboratories (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Gelnova Laboratories (India) Private Limited has 19 MSME Form 1 returns on record between 2013 and 2023, listing 1,674 overdue payments to 124 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 124)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Gelnova Laboratories (India) Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Gelnova Laboratories (India) Private Limited has a workforce of 82 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.
GST
Gelnova Laboratories (India) has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCG6002C1Z9 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Gelnova Laboratories (India) Private Limited, buy the company report.
Recent activity
Gelnova Laboratories (India) Private Limited has 7 board changes on record since 2000: 3 appointments and 4 cessations. The latest: Jatin Vasant Thakkar was appointed as Managing Director on 30 Sep 2015.
24 earlier events are in the company report.
Frequently asked questions
Gelnova Laboratories (India) is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 January 1997 (29+ years old) and is registered under CIN U17000MH1997PTC105076.
Gelnova Laboratories (India) has 3 current directors:
- Jatin Vasant Thakkar - Managing Director
- Bharati Vasant Thakkar - Director
- Dhananjay Thakorbhai Desai - Director
The latest financial statements of Gelnova Laboratories (India) on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Gelnova Laboratories (India) is 27AABCG6002C1Z9, registered in Maharashtra.
The CIN (Corporate Identification Number) of Gelnova Laboratories (India) is U17000MH1997PTC105076. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gelnova Laboratories (India) has 21 court cases on record: 18 filed by the company and 3 filed against it. Most are in the high courts.
Gelnova Laboratories (India) was incorporated on 14 January 1997, making it 29+ years old. It is registered with the Registrar of Companies, Mumbai.
Gelnova Laboratories (India) has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹50 Lakh; the latest was in March 2023.
The peers of Gelnova Laboratories (India) by revenue are MDC Pharmaceuticals Limited, DNV Overseas Impex Private Limited, Unijules Life Sciences Limited, Revat Laboratories Private Limited, Mistair Health and Hygiene Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jatin Vasant Thakkar was appointed as Managing Director on 30 Sep 2015. Jatin Vasant Thakkar ceased to be Director on 12 Mar 2015. Rusi Nusserwanji Sethna ceased to be Director on 11 May 2014. Gelnova Laboratories (India) has 7 board changes on record in total.
Yes, Gelnova Laboratories (India) is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0009899).
Gelnova Laboratories (India) has 19 MSME Form 1 returns on record between 2013 and 2023, listing 1,674 overdue payments to 124 micro and small suppliers. The latest return was filed on 16 Dec 2023.

